Home/Filings/4/0000914190-18-000294
4//SEC Filing

Bove Mauro 4

Accession 0000914190-18-000294

CIK 0000707511other

Filed

Jul 18, 8:00 PM ET

Accepted

Jul 19, 5:10 PM ET

Size

6.8 KB

Accession

0000914190-18-000294

Insider Transaction Report

Form 4
Period: 2018-07-17
Bove Mauro
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-07-17$0.21/sh+200,000$42,000325,000 total
    Exercise: $0.21Exp: 2028-07-17Common Stock (200,000 underlying)
Holdings
  • Stock Option (right to buy)

    Exercise: $0.28Exp: 2027-09-01Common Stock (125,000 underlying)
    125,000
Footnotes (2)
  • [F1]The option vests in four equal annual installments beginning on September 1, 2017.
  • [F2]The option vests in four equal installments of 50,000 shares on each of July 17, 2018, 2019, 2020 and 2021.

Issuer

REGENERX BIOPHARMACEUTICALS INC

CIK 0000707511

Entity typeother

Related Parties

1
  • filerCIK 0001396271

Filing Metadata

Form type
4
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 5:10 PM ET
Size
6.8 KB